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1. Introduction 
Glutamate dehydrogenase (EC 1.4.1.3) is an allo- 
steric protein with a large number of powerful 
catalytic modifiers of diverse nature, e.g. nucleotides 
(GTP, ADP, ATP) [1,2], metal ions (Zn 2.) [3], 
steroids (diethylstilbestrol) [4], amino acids (leucine, 
isoleucine, methionine, norvaline) [5]. The nucleo- 
tides are the most interesting allosteric effectors 
because of their opposite ffects. ADP is an activator 
[1,6,7] while GTP is an inhibitor [1,2,6] of both 
NAD(P)H oxidation and NAD(P) ÷ reduction. ATP 
inhibits the NADH oxidation, does not influence the 
NADPH oxidation and activates the NAD ÷ and NADP ÷ 
reduction [1,6]. 5'-AMP activates and 5'-GMP inhibits 
both the forward and backward reactions with the 
two cofactors [6]. 
In the present study we have found that 5.10 -4 M 
cAMP activates the reductive amination of oxoglutarate 
about two-fold with NADH and three-fold with 
NADPH and does not effect the oxidative deamina- 
tion of glutamate with both NAD and NADP. Dibutyryl- 
cAMP inhibits glutamate dehydrogenase, which is 
probably due to the butyric moiety of the molecule, 
because the free butyric acid has an inhibitory effect. 
Cyclic 3', 5'-guanosine monophosphate (cGMP) also 
inhibits the enzyme. 
2. Materials and methods 
Crystalline bovine liver glutamate dehydrogenase 
was obtained from Boehringer whereas mitochondrial 
extracts from rat liver, brain and testis were used as 
crude enzyme preparations. A stock solution of 200 
/~g/ml of Boehringer glutamate dehydrogenase was 
prepared in Tris-HC1 buffer, pH 7.6, from which 
0.010 ml aliquots were taken per 2 ml reaction mix- 
ture. Mitochondria from rat liver were prepared 
according to Schneider [8], from rat brain by the 
method of Whittaker and Barker [9] and from rat 
testis according to Sulimovici [10]. The particles were 
disrupted with 0.5% Triton X-100 and then centri- 
fuged at 140 000 g for 1 h and the resulting super- 
natant was used for glutamate dehydrogenase activity 
estimation. The reaction mixture (final vol 2 ml) for 
determination of enzyme activity in the reductive 
direction consisted of 50 mM Tris-HC1 buffer, pH 
7.6, 5 mM oxoglutarate, 0.1 mM NAD(P)H, 50 mM 
NH4C1 and the enzyme; in the oxidative direction it 
consisted of 50 mM Tris-HC1 buffer, pH 7.6, 2.5 mM 
glutamate, 1 mM NADP ÷ and the enzyme. Cyclic 
AMP and cyclic GMP (free acids) were dissolved in the 
assay mixture buffer, dibutyryl-cAMP in distilled water. 
These substances were added to the reaction mixture 
at the concentrations shown in the figs. and tables. 
The changes in the optical density at 340 nm were 
measured at 25°C in a cell with 1 cm light path at 
30 sec intervals. The specific activity of the enzyme 
was expressed as/amoles NAD(P)H oxidized or 
NAD(P) ÷ reduced per min per mg protein. 
cAMP, cGMP, dibutyryl-cAMP, Na-oxoglutarate, 
glutamate, NAD, NADP, NADH, NADPH and Tris 
were from Boehringer; NH4C1 was from Merck. 
3. Results 
Fig. 1 shows that cAMP enhanced the activity of 
crystalline bovine liver glutamate dehydrogenase with 
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Fig.1. Cyclic AMP concentration-dependent activation of 
bovine liver glutamate dehydrogenase. S e text for details. 
oxoglutarate, NH4 and NAD(P)H as substrates. The 
NADPH-dependent reaction was more sensitive to 
cAMP than the NADH-dependent one: a 50% activa- 
tion was observed at 5.10 -s M cAMP with NADPH and 
at 2.10 -4 M cAMP with NADH. At 5.10-4 M, cAMP 
activated the reductive amination of oxoglutarate 
with NADH about two-fold and with NADPH about 
three-fold. The saturation plateau is between 7.10 -4 
and 1.10 -3 M. The activation was independent of the 
incubation time. 
The oxidative deamination of glutamate was not 
influenced by cAMP even at 1 mM (5.9/amol NADP 
and 8.8/1tool NAD reduced per min per mg protein 
in comparison with 7.0/~mol and 9.2/amol, respec- 
tively, in the presence of cAMP). 
The activation by cAMP increased with the satura- 
tion of the enzym e with the substrates: oxoglutarate, 
NH~ and NAD(P)H (Fig.2). We did not find any pH 
dependence (between 7.0 and 9.0) for the activation 
of glutamate dehydrogenase by cAMP (results not 
shown here). Only at pH 9.0, when the enzyme activity 
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Fig.2. Activation of bovine liver glutamate dehydrogenase 
by cAMP in relation to the substrate concentrations. See 
text for details. 
cAMP rise to 430 and 330% for the NADPH- and 
NADH-dependent reactions, respectively. 
At 0.5 raM, dibutyryl-cAMP (table 1) inhibited the 
reaction with NADPH and NADH to the extent of 
35 and 80%, respectively. At 0.8 mM, cAMP restored 
the NADPH-linked activity up to the control evels, 
but not the NADH-linked activity. This inhibition was 
probably due to the butyric moiety of the molecule 
because free butyric acid itself at equivalent concentra- 
tions had an inhibitory effect. Cyclic GMP at 0.5 mM 
also inhibited the enzyme by 53 and 31% for NADPH- 
and NADH-dependent glutamate dehydrogenase, 
respectively (table 1). When 0.8 mM cAMP were added 
to the cGMP-inhibited enzyme the activity was enhanc- 
ed as if cGMP were not present in the reaction mixture. 
We also tested the effect of cAMP on glutamate 
dehydrogenase in mitochondrial matrix from rat liver, 
brain and testis (table 2). In all mitochondrial prepara- 
tions cAMP activated glutamate dehydrogenase, 2.5- 
to 3-fold with NADH and 6- to 7-fold with NADPH. 
This confirmed the results obtained with the crysta]- 
lyne enzyme that the NADPH-linked reaction was 
more sensitive than the NADH one. The oxidative 
deamination of glutamate with mitochondrial enzyme 
was also unaffected by cAMP. 
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Table 1 
Influence of cAMP, dibutyryl-cAMP and cGMP on bovine liver glutamate dehydrogenase ctivity 
December 1975 
Additions Glutamate dehydrogenase 
NADPH-dependent NADH-dependent 
Specific activity % activity Specific a tivity % activity 
1. Control (without additions) 10.3 
2. + 0.8 mM cAMP 29.3 
3. + 0.5 mM Dibutyryl-cAMP 6.7 
4. + 0.5 mM Dibutyryl-cAMP +0.8 mM cAMP 10.6 
5. + 0.5 mM Butyric acid 4.0 
6. + 0.5 mM cGMP 4.8 
7. + 0.5 mM cGMP + 0.8 mM cAMP 30.7 
100 20.9 100 
284 39.1 187 
66 4.0 19 
103 12.4 59 
40 5.8 24 
47 14.5 69 
298 38.6 185 
Protein content was determined by the standard Lowry procedure. Other details in text. 
4. Discussion 
It is well known that cAMP stimulates the activity 
of a number of enzymes uch as muscle phosphorylase, 
epididymal fat pad lipase, phosphofructokinase nd 
tyrosine aminotransferase, whereas it inhibits 
fructose 1,6-diphosphatase and glycogen synthetase 
[11]. We now find that 3',5'-cyclic AMP activates in 
vitro both purified bovine liver glutamate dehydrogenase 
and the enzyme from rat liver, brain and testis mito- 
chondrial preparations. However the concentrations 
of cAMP which affect glutamate dehydrogenase are 
much higher than those which occur in vivo. In this 
respect he physiological meaning of the phenomenon 
observed is not clear, but it is of interest from the 
enzymological point of view. 
It is established that bovine liver glutamate 
dehydrogenase i  an allosteric protein, being a tetramer 
with a mol. wt of 1 000 000 [3,12,13]. Upon dilu- 
tion [14] and at high concentration f NADH [15] 
the enzyme dissociates to subunits with a molecular 
weight of 250 000. Frieden [15] has suggested that 
the allosteric effectors influenced the catalytic activity 
by changing the state of aggregation. It might be 
assumed that cAMP activates the enzyme in the same 
manner by altering the equilibrium between monomers 
and associated forms. At the same time, since cAMP 
activates only the reductive amination of oxoglutarate, 
it is possible that the enzyme-cAMP complex becomes 
the 'active nzyme' for oxoglutarate, NH4 and 
NAD(P)H, but not for glutamate and NAD(P) ÷, thus 
facilitating the formation of the enzyme-substrate 
complex at the substrate saturation concentrations. It 
is not surprising to find that cGMP has an inhibitory 
effect on account of the mutually opposite action of 
the two cyclic nucteotides. The fact that higher con- 
Table 2 






Specific activity % activity Specific activity % activity 
Rat liver None 0.22 100 0.03 100 
+ 1 mMcAMP 0.69 315 0.23 706 
Rat brain None 0.14 100 0.02 100 
+ 1 mM cAMP 0.34 303 0.13 670 
Rat testes None 0.010 100 0.001 - 
+ 1 mM cAMP 0.025 250 0.006 - 
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centrations of cAMP overcome cGMP inhibition prob- 
ably shows a competition for the same binding site. 
It is well known that adenyl cyclase is a component 
of the plasma membrane, but in some tissues this 
enzyme was shown to be bound to other intracellular 
membranes. In the brain it is localized predominantly 
in the microsomal nd mitochondrial fractions [16]; 
in dog [17] and rat [18] testes it is also bound to the 
mitochondrial membranes. Sulimovici and Lunenfeld 
[19] have shown that both outer and inner rat testis 
mitochondrial membranes contain adenyl cyclase 
activity. This was the reason for testing the effect of 
cAMP in mitochondrial g utamate dehydrogenase from 
rat brain and testis tissues. The question of glutamate 
dehydrogenase activation by cAMP in the liver mito- 
chondria is now open, because there are no data about 
adenyl cyclase activity of their membranes. 
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